We are live on ! Find out more
NAM

NorthCrest Asset Manangement Portfolio holdings

AUM $3.89B
1-Year Est. Return 40.33%
This Fund
S&P 500
This Quarter Est. Return
+12.47%
1 Year Est. Return
+40.33%
3 Year Est. Return
+119.87%
5 Year Est. Return
10 Year Est. Return
AUM
$1.76B
AUM Growth
-$87M
Cap. Flow
-$268M
Cap. Flow %
-15.23%
Top 10 Hldgs %
20.42%
Holding
445
New
14
Increased
127
Reduced
209
Closed
54

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$19.6M
2
PG icon
Procter & Gamble
PG
+$17.3M
3
PEP icon
PepsiCo
PEP
+$16.4M
4
VZ icon
Verizon
VZ
+$16.2M
5
IAU icon
iShares Gold Trust
IAU
+$14.5M

Sector Composition

Rank Sector Weight
1 Technology 26.67%
2 Healthcare 16.91%
3 Industrials 16.1%
4 Financials 14.98%
5 Consumer Discretionary 6.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIR icon
351
Vir Biotechnology
VIR
$1.5B
$289K 0.02%
11,400
+800
+8% +$19.6K
XYZ
352
Block Inc
XYZ
$47.6B
$284K 0.02%
4,517
-1,730
-28% -$107K
NTAP icon
353
NetApp
NTAP
$39.4B
$281K 0.02%
4,679
-2,000
-30% -$133K
TTWO icon
354
Take-Two Interactive
TTWO
$47.1B
$277K 0.02%
2,660
-100
-4% -$10.8K
EEM icon
355
iShares MSCI Emerging Markets ETF
EEM
$29.9B
$276K 0.02%
7,273
-60
-0.8% -$2.21K
SYY icon
356
Sysco
SYY
$40.3B
$274K 0.02%
+3,585
New +$290K
CYH icon
357
Community Health Systems
CYH
$412M
$272K 0.02%
63,000
+31,000
+97% +$95.4K
ED icon
358
Consolidated Edison
ED
$39.4B
$267K 0.02%
2,804
-2,205
-44% -$201K
BLFS icon
359
BioLife Solutions
BLFS
$1.69B
$262K 0.01%
14,400
+1,500
+12% +$31K
LIVN icon
360
LivaNova
LIVN
$4.18B
$258K 0.01%
4,640
+300
+7% +$15.3K
L icon
361
Loews
L
$23.3B
$236K 0.01%
4,050
MTCH icon
362
Match Group
MTCH
$8.43B
$235K 0.01%
5,671
-258
-4% -$11.7K
NOW icon
363
ServiceNow
NOW
$132B
$232K 0.01%
2,990
-4,240
-59% -$331K
KLAC icon
364
KLA
KLAC
$253B
$227K 0.01%
+6,030
New +$210K
SSYS icon
365
Stratasys
SSYS
$765M
$227K 0.01%
19,180
+800
+4% +$10.7K
BX icon
366
Blackstone
BX
$112B
$220K 0.01%
2,960
-8
-0.3% -$691
AJG icon
367
Arthur J. Gallagher & Co
AJG
$64.6B
$217K 0.01%
+1,149
New +$215K
RDN icon
368
Radian Group
RDN
$4.82B
$215K 0.01%
11,300
FANG icon
369
Diamondback Energy
FANG
$55.5B
$213K 0.01%
+1,556
New +$227K
ZTS icon
370
Zoetis
ZTS
$30.6B
$213K 0.01%
+1,450
New +$215K
USB icon
371
US Bancorp
USB
$99.8B
$203K 0.01%
+4,650
New +$199K
FFIV icon
372
F5
FFIV
$23.5B
$202K 0.01%
1,410
-1,650
-54% -$242K
EXEL icon
373
Exelixis
EXEL
$13B
$181K 0.01%
11,280
-296
-3% -$4.83K
MYGN icon
374
Myriad Genetics
MYGN
$313M
$173K 0.01%
11,950
+1,550
+15% +$28.9K
CLS icon
375
Celestica
CLS
$36.6B
$165K 0.01%
14,600
+1,000
+7% +$10.5K

Similar funds

NorthCrest Asset Manangement's Q4 2022 Portfolio in Review

As of Q4 2022, NorthCrest Asset Manangement held 445 positions worth $1.76B, down 4.7% from $1.85B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

NorthCrest Asset Manangement withdrew a net $268M in Q4 2022, closing 54 positions and reducing 209 holdings. Its most notable exit was PepsiCo, an estimated $16.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, NorthCrest Asset Manangement opened a new position in State Street SPDR S&P MIDCAP 400 ETF Trust worth $1.6M.

  • NorthCrest Asset Manangement's largest Q4 2022 buy was State Street SPDR S&P MIDCAP 400 ETF Trust: 3,605 shares worth $1.6M.
  • NorthCrest Asset Manangement added most to State Street SPDR S&P 500 ETF Trust in Q4 2022, an estimated $4.85M increase.
  • NorthCrest Asset Manangement's biggest Q4 2022 reduction was Pfizer, cutting an estimated $19.6M.
  • NorthCrest Asset Manangement fully exited PepsiCo in Q4 2022, selling an estimated $16.4M.
  • NorthCrest Asset Manangement's ten largest holdings make up 20% of its $1.76B portfolio in Q4 2022.
  • NorthCrest Asset Manangement opened 14 new positions and closed 54 in Q4 2022.
  • NorthCrest Asset Manangement's portfolio value fell 4.7% quarter-over-quarter to $1.76B.

Based on NorthCrest Asset Manangement's 13F filing for Q4 2022, filed 1 Feb 2023.